Skip to main content
KBS_Icon_questionmark link-ico


Deborah started her PhD on blood biomarkers for Alzheimer’s disease in Down syndrome at the IoPP, primarily focusing on amyloid and tau in relation to dementia status. She is involved in the LonDownS consortium and funded by the NIHR Maudsley Biomedical Research Centre. Deborah has a MSc Degree in Clinical Psychology & Neuroscience from the University of Basel and is experienced in assessing cognitive performance in clinical as well as non-clinical populations. During her master's, she investigated how genetic variants influence cognitive performance, with a particular focus on episodic memory. Moreover, she has been involved in assessing psychosis risk in the general population, and in conducting neuropsychological assessments for clinical trials with Multiple Sclerosis patients. Deborah has also collaborated in multiple genetic studies investigating cognitive functions in healthy adults and explored the relationship between intelligence and neuronal counts across taxa as a visiting researcher at Trinity College Dublin. 

Research Interests

  •  Alzheimer’s disease and dementia (in Down syndrome) 
  •  Fluid biomarkers for Alzheimer’s disease 
  •  Neurodegeneration 

Research Groups

London Down Syndrome (LonDownS) Consortium  

Expertise and Public Engagement

Activity stand for our participants and interested members of the public at the World Down Syndrome Day celebration.